nanoparticles via injection are believed to target tumors by passive (for example, by enhanced permeability and retention (EPR) effect) and/or active (for example, ligand-mediated) targeting . However,the injected nanoparticles tend to accumulate in the EPR organs such as the liver and spleen and there may be long-term
harmful effects